PCM
MGNX icon

Prelude Capital Management’s MacroGenics MGNX Stock Holding History

Prelude Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,334
Closed -$60.9K – 1450
2024
Q2 		$60.9K Buy
+14,334
New +$140K ﹤0.01% 1137
2024
Q1 		– Sell
-30,200
Closed -$291K – 1455
2023
Q4 		$291K Buy
30,200
+19,800
+190% +$137K 0.02% 750
2023
Q3 		$48.5K Sell
10,400
-2,974
-22% -$14.8K ﹤0.01% 1047
2023
Q2 		$71.6K Buy
+13,374
New +$82.5K ﹤0.01% 958
2020
Q4 		– Sell
-200
Closed -$5K – 1702
2020
Q3 		$5K Buy
200
+100
+100% +$2.73K ﹤0.01% 1563
2020
Q2 		$3K Buy
+100
New +$1.74K ﹤0.01% 1786
2020
Q1 		– Sell
-800
Closed -$9K – 1804
2019
Q4 		$9K Buy
+800
New +$7.92K ﹤0.01% 1721
2019
Q3 		– Sell
-272
Closed -$5K – 1916
2019
Q2 		$5K Buy
+272
New +$4.67K ﹤0.01% 1522
2019
Q1 		– Sell
-1,223
Closed -$16K – 2005
2018
Q4 		$16K Buy
1,223
+1,023
+512% +$17.2K ﹤0.01% 1284
2018
Q3 		$4K Buy
+200
New +$4.26K ﹤0.01% 1646
2018
Q2 		– Sell
-254
Closed -$6K – 1825
2018
Q1 		$6K Buy
+254
New +$6.17K ﹤0.01% 1405
2017
Q1 		– Sell
-2,000
Closed -$41K – 1660
2016
Q4 		$41K Buy
2,000
+800
+67% +$20.1K 0.01% 1101
2016
Q3 		$36K Buy
1,200
+23
+2% +$684 ﹤0.01% 1148
2016
Q2 		$32K Buy
1,177
+515
+78% +$11.6K ﹤0.01% 1147
2016
Q1 		$12K Sell
662
-1,338
-67% -$25.5K ﹤0.01% 1156
2015
Q4 		$62K Sell
2,000
-500
-20% -$15.2K 0.01% 989
2015
Q3 		$54K Buy
2,500
+700
+39% +$22K 0.01% 1039
2015
Q2 		$68K Buy
1,800
+400
+29% +$13.1K 0.01% 1037
2015
Q1 		$44K Sell
1,400
-2,400
-63% -$81.3K 0.01% 1366
2014
Q4 		$133K Buy
+3,800
New +$94.7K 0.02% 895

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's MGNX Position: Q3 2024 in Review

Prelude Capital Management sold out of MacroGenics (MGNX) in Q3 2024, closing a stake of 14,334 shares — an estimated $60.9K sold.

Prelude Capital Management first reported a position in MGNX in Q4 2014 and held it in 20 quarters. The position peaked at $291K in Q4 2023. 124 funds tracked by Wall St. Rank hold MGNX as of Q3 2024.

  • Prelude Capital Management reported no remaining MacroGenics position as of Q3 2024 after selling out during the quarter.
  • Prelude Capital Management sold 14,334 MacroGenics shares in Q3 2024, an estimated $60.9K.
  • Prelude Capital Management first reported a position in MacroGenics in Q4 2014 and held it in 20 quarters.
  • Prelude Capital Management's MacroGenics position peaked at $291K in Q4 2023.
  • 124 funds tracked by Wall St. Rank held MacroGenics as of Q3 2024.

Based on Prelude Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.